R1	Has_qualifier Arg1:T3 Arg2:T4	
R2	AND Arg1:T3 Arg2:T2	
R3	AND Arg1:T3 Arg2:T1	
R4	Has_value Arg1:T5 Arg2:T6	
R5	Has_qualifier Arg1:T13 Arg2:T15	
*	OR T12 T13 T14
R6	Subsumes Arg1:T11 Arg2:T12	
R7	Has_value Arg1:T21 Arg2:T22	
R8	Has_value Arg1:T31 Arg2:T32	
R9	Has_value Arg1:T33 Arg2:T32	
R10	Has_value Arg1:T36 Arg2:T37	
R11	Has_value Arg1:T34 Arg2:T35	
R12	Has_value Arg1:T29 Arg2:T30	
R13	Has_value Arg1:T27 Arg2:T28	
R14	Has_value Arg1:T25 Arg2:T26	
R15	Has_value Arg1:T23 Arg2:T24	
T1	Procedure 0 10	Histologic
T2	Procedure 14 23	cytologic
T3	Condition 51 56	NSCLC
T4	Qualifier 37 50	stage IIIB/IV
T5	Measurement 58 65	ECOG PS
T6	Value 67 70	0,1
T7	Undefined_semantics 105 123	measurable disease
T8	Qualifier 105 115	measurable
T9	Subjective_judgement 105 115	measurable
T10	Non-query-able 72 123	Unidimensional or bi-dimensional measurable disease
T11	Procedure 139 148	treatment
T12	Procedure 170 197	platinum-based chemotherapy
T13	Procedure 208 232	second-line chemotherapy
T14	Drug 237 257	1 EGF/EGFR inhibitor
T15	Qualifier 199 207	standard
T17	Condition 271 290	disease progression
T18	Observation 259 267	Evidence
T19	Subjective_judgement 259 290	Evidence of disease progression
T20	Undefined_semantics 259 290	Evidence of disease progression
T21	Observation 292 307	Life expectancy
T22	Value 308 317	>12 weeks
T23	Measurement 319 330	Neutrophils
T24	Value 331 342	> 1.5 109/l
T25	Measurement 344 353	Platelets
T26	Value 354 365	> 100 109/l
T27	Measurement 367 377	Hemoglobin
T28	Value 378 385	> 9g/dl
T29	Measurement 387 402	Total bilirubin
T30	Value 403 412	< 1.5 UNL
T31	Measurement 429 439	ALT (SGPT)
T32	Value 440 449	< 2.5 UNL
T33	Measurement 414 424	AST (SGOT)
T34	Measurement 451 472	Alkaline phosphatases
T35	Value 473 480	< 5 UNL
T36	Measurement 482 492	Creatinine
T37	Value 493 500	< 1 UNL
